Firefly Neuroscience Inc. logo

Firefly Neuroscience Inc.

AIFF | NASDAQ
Chart Builder DCF Calculator
$1.20
-$0.03 (-2.44%)
At close: Sep 22, 2026, 4:00 PM ET
$1.15
-$0.05 (-4.14%)
After-hours: Sep 22, 2026, 7:36 PM ET

Company Profile

Based in Toronto, Canada, Firefly Neuroscience, Inc. is a medical technology and artificial intelligence firm specializing in developing neuroscientific solutions. The company's primary goal is to enhance patient outcomes for individuals affected by mental illnesses and neurological disorders. Its flagship product, Brain Network Analytics, is a sophisticated software platform engineered to aid in the diagnosis and treatment of a diverse range of cognitive and psychiatric conditions. These conditions encompass, but are not limited to, depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. Firefly Neuroscience, Inc. caters to both pharmaceutical companies and medical practitioners.

Key Executives

Name Position
Greg Lipschitz Chief Executive Officer & Director
David DeCaprio President, Chief Operating Officer & Director
Paul Krzywicki Chief Financial Officer & Company Secretary
Gil Issachar Head of AI & Neuroscience

Latest SEC Filings

No SEC filings available
View All SEC Filings
Firefly Neuroscience Inc.
Firefly Neuroscience Inc. logo
Country United States
IPO Date Nov 27, 2002
Industry Software - Application
Sector Technology
Employees 17
CEO Greg Lipschitz

Contact Details

1100 Military Road Kenmore, New York 14217 United States

Stock Details

Ticker Symbol AIFF
Exchange NASDAQ
Fiscal Year n/a
Reporting Currency USD
CIK Code 0000803578
CUSIP Number 317970101
ISIN Number US3179701012
SIC Code n/a

© 2026 bestshares.com. All rights reserved.